Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Church & Dwight divests brands

This article was originally published in The Tan Sheet

Executive Summary

Langhorne, Pa.-based Insight Pharmaceuticals looks to strengthen its OTC drug position with the purchase of seven brands from Church & Dwight - Auro-Dri, Boil Ease, Dermarest, Gentle Naturals, Pronto, Skin Shield and Stye - the company announces June 17. C&D acquired the brands as part of its purchase of Del Labs from Coty last year, an acquisition it made to obtain the Orajel brand. The divestiture is in line with C&D's strategy of making bolt-on acquisitions and discarding underperforming assets (1"The Tan Sheet" April 6, 2009)

You may also be interested in...

Experts Predict Buyer's Market For Consumer Brands In 2010

Industry stakeholders and experts anticipate merger and acquisition activity in the consumer health and personal care sectors will accelerate in 2010 as the buyer's market continues to grow

C&D’s Act May Be Hard To Follow For Drug Firms Considering Bolt-Ons

Church & Dwight CEO James Craigie has a few words of wisdom on bolt-on acquisitions, recently a popular buzzword among big pharmas looking for savings

GNC In Rough Seas From COVID-19 Pandemic; Vitamin Shoppe Safe In Port Under New Owner

GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts